<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02428023</url>
  </required_header>
  <id_info>
    <org_study_id>404 General Military Hospital</org_study_id>
    <nct_id>NCT02428023</nct_id>
  </id_info>
  <brief_title>B-Thalasaemia Trait and Its Possible Cardioprotective Role</brief_title>
  <official_title>B-Thalasaemia Trait and Its Possible Cardioprotective Role</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>404 General Military Hospital, Larissa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>404 General Military Hospital, Larissa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our purpose is to investigate whether thallasaemia trait offers protection against
      cardiovascular events and whether this can be applied to specific characteristics of these
      people ( better lipid profile , better blood pressure profile) as scientific literature
      suggests.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Thallasaemia is a major problem , especially in countries around the Mediterranean sea.On the
      other hand ,thallasaemia trait has been shown ,in a small number of studies , to have a
      possible protective role against CAD and stroke.These kind of studies have been contacted in
      Greece also ,and usually they enroll a small number of participants. In the study,
      investigators will enroll 2500 subjects who serve in military units in Thesally Greece.
      Firstly investigators will estimate the prevalence of thallasaemia trait in this population ,
      as it is very high in this region and at the same time investigators will retrospectively
      record data from their personal files (which are annually recorded).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Cardioprotective role of Thalassemia Treat</measure>
    <time_frame>1 YEAR</time_frame>
    <description>Cardioprotective role of Thalassemia Treat</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">2500</enrollment>
  <condition>Beta-Thalassemia Trait</condition>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>GrThalasaemia</arm_group_label>
    <description>estimation of IMT of the carotides arteries and calcium scoring</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GrNormal</arm_group_label>
    <description>estimation of IMT of the carotides arteries and calcium scoring</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        2500 subjects who serve in military units in Thessaly Greece
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. voluntary participation,

          2. Subjects with Thalassemia treat will be confirmed of their treat by electrophoresis -

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>57 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elias Andreanidis, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>404 General Military Hospital, Larissa</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elias Andreanidis, PhD</last_name>
    <phone>+3 6944570406</phone>
    <email>elandreanides@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maria Malliarou, PhD</last_name>
    <phone>+3 6944796499</phone>
    <email>mmalliarou@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>404 Military Hospital</name>
      <address>
        <city>Larissa</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ELIAS ANDREANIDES, PhD</last_name>
      <phone>+3 6944570406</phone>
      <email>elandreanides@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Maria Malliarou, PhD</last_name>
      <email>mmalliarou@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 23, 2015</study_first_submitted>
  <study_first_submitted_qc>April 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 28, 2015</study_first_posted>
  <last_update_submitted>January 8, 2016</last_update_submitted>
  <last_update_submitted_qc>January 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>404 General Military Hospital, Larissa</investigator_affiliation>
    <investigator_full_name>ANDREANIDIS ELIAS</investigator_full_name>
    <investigator_title>Director of Cardiology Department</investigator_title>
  </responsible_party>
  <keyword>Thalassemia</keyword>
  <keyword>trait</keyword>
  <keyword>coronary</keyword>
  <keyword>stroke</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Thalassemia</mesh_term>
    <mesh_term>beta-Thalassemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

